15.2.2021 CELLINK has entered into an agreement to acquire the advanced robotics and diagnostics automation company Ginolis

CELLINK AB (publ) has entered into an agreement with the shareholders of Ginolis Oy to acquire all shares

for a purchase price on cash- and debt-free basis of 70M euros (the ”Acquisition”).

Ginolis Oy is a leading provider of robot-based automation solutions used world-wide to manufacture a

variety of medical disposables and point-of-care tests such as Covid-19 tests.

Read more

Ota yhteyttä